H1B Report
Side-by-side comparison

INFOSYS LIMITED vs Takeda Pharmaceuticals USA, Inc.

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
INFOSYS LIMITED
TXRank #1FEIN 58-1760235
Entity B
Takeda Pharmaceuticals USA, Inc.
MARank #FEIN 13-4013710

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricINFOSYS LIMITEDTakeda Pharmaceuticals USA, Inc.
Total filings200,329204
Certified %99.55%81.86%
Denied %0.21%1.47%
Withdrawn %0.20%1.96%
Cert-withdrawn %0.05%14.71%
Rank#1
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateTXMA

Outcomes — INFOSYS LIMITED

DOL case-status mix.

Outcome breakdown: Certified 99.5%, Cert-withdrawn 0.0%, Withdrawn 0.2%, Denied 0.2%
Outcome breakdown
OutcomeShare
Certified99.5%
Cert-withdrawn0.0%
Withdrawn0.2%
Denied0.2%
Certified99.5%
Cert-withdrawn0.0%
Withdrawn0.2%
Denied0.2%

Outcomes — Takeda Pharmaceuticals USA, Inc.

DOL case-status mix.

Outcome breakdown: Certified 81.9%, Cert-withdrawn 14.7%, Withdrawn 2.0%, Denied 1.5%
Outcome breakdown
OutcomeShare
Certified81.9%
Cert-withdrawn14.7%
Withdrawn2.0%
Denied1.5%
Certified81.9%
Cert-withdrawn14.7%
Withdrawn2.0%
Denied1.5%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

INFOSYS LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,138
FY20111,681
FY201214,633
FY201331,994
FY201423,467
FY201532,976
FY201624,049
FY201720,254
FY201811,519
FY201921,102
FY202016
FY202129
FY202222
FY20232,269
FY20245,943
FY20255,790
FY20262,447
Takeda Pharmaceuticals USA, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102
FY20110
FY20122
FY201310
FY20141
FY20155
FY201610
FY20175
FY20188
FY20196
FY20205
FY202126
FY202210
FY202319
FY202442
FY202547
FY20266

Top 5 occupations — INFOSYS LIMITED

Top 5 occupations — Takeda Pharmaceuticals USA, Inc.

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.